Myopia
Not recruitingStudy of Atropine Sulfate eye drops (0.
- Disease:Myopia
- Substances:Atropine Sulfate
United Kingdom- Participants:0–17 years
- Substances:Atropine Sulfate
- Sponsor:Ocumension (Hong Kong) Ltd.
Rare diseases
Investigational molecules
Locations
Back to the United Kingdom1 clinical trial in Grengegorman, United Kingdom. Every trial is listed in the EU Clinical Trials Register and updated daily.
United KingdomThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on treating myopia progression in pediatric patients, exploring new therapeutic approaches for vision care management.
Research efforts aim to evaluate novel treatments for controlling childhood nearsightedness, potentially offering new solutions for young patients struggling with progressive vision changes.
Dedicated studies examining the effectiveness of new ophthalmic solutions in managing vision disorders among children, with a focus on long-term treatment outcomes.
These trials represent significant advances in pediatric ophthalmology, investigating safe and effective interventions for young patients with progressive vision conditions.
Comprehensive research into vision disorders affecting young populations, utilizing controlled clinical studies to advance understanding and treatment options.
The studies emphasize the importance of early intervention and monitoring in pediatric vision care, with potential implications for future treatment protocols.
Tell us about your condition – we search every trial in Europe and connect you with the right site.